Allergy Asthma Immunol Res.  2011 Jul;3(3):157-167. 10.4168/aair.2011.3.3.157.

Occupational Asthma: Etiologies and Risk Factors

• Vandenplas O

• KMID: 1803321
• DOI: http://doi.org/10.4168/aair.2011.3.3.157

Abstract

The purpose of this article is to critically review the available evidence pertaining to occupational, environmental, and individual factors that can affect the development of occupational asthma (OA). Increasing evidence suggests that exploration of the intrinsic characteristics of OA-causing agents and associated structure-activity relationships offers promising avenues for quantifying the sensitizing potential of agents that are introduced in the workplace. The intensity of exposure to sensitizing agents has been identified as the most important environmental risk factor for OA and should remain the cornerstone for primary prevention strategies. The role of other environmental co-factors (e.g., non-respiratory routes of exposure and concomitant exposure to cigarette smoke and other pollutants) remains to be further delineated. There is convincing evidence that atopy is an important individual risk factor for OA induced by high-molecular-weight agents. There is some evidence that genetic factors, such as leukocyte antigen class II alleles, are associated with an increased risk of OA; however, the role of genetic susceptibility factors is likely to be obscured by complex gene-environment interactions. OA, as well as asthma in general, is a complex disease that results from multiple interactions between environmental factors and host susceptibilities. Determining these interactions is a crucial step towards implementing optimal prevention policies.

Keyword

Allergy; asthma; occupational disease

MeSH Terms

Alleles
Asthma
Asthma, Occupational
Gene-Environment Interaction
Genetic Predisposition to Disease
Hypersensitivity
Leukocytes
Occupational Diseases
Primary Prevention
Risk Factors
Smoke
Structure-Activity Relationship
Tobacco Products
Smoke

Reference

1. Vandenplas O, Malo JL. Definitions and types of work-related asthma: a nosological approach. Eur Respir J. 2003. 21:706–712.

2. Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe B, Heitzer J. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008. 134:1S–41S.

3. Torén K, Blanc PD. Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med. 2009. 9:7.

4. Vandenplas O. Socioeconomic impact of work-related asthma. Expert Rev Pharmacoecon Outcomes Res. 2008. 8:395–400.

5. Maestrelli P, Boschetto P, Fabbri LM, Mapp CE. Mechanisms of occupational asthma. J Allergy Clin Immunol. 2009. 123:531–542. quiz 43-4.

6. Palikhe NS, Kim JH, Park HS. Biomarkers predicting isocyanate-induced asthma. Allergy Asthma Immunol Res. 2011. 3:21–26.

7. Shakib F, Ghaemmaghami AM, Sewell HF. The molecular basis of allergenicity. Trends Immunol. 2008. 29:633–642.

8. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, Karp CL. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature. 2009. 457:585–588.

9. Baur X. Enzymes as occupational and environmental respiratory sensitisers. Int Arch Occup Environ Health. 2005. 78:279–286.

10. Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, Magoski NM, Karol MH, Bottomly K, Redlich CA. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med. 2000. 162:2330–2336.

11. Choi JH, Nahm DH, Kim SH, Kim YS, Suh CH, Park HS, Ahn SW. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. Ann Allergy Asthma Immunol. 2004. 93:293–298.

12. Agius RM. Why are some low-molecular-weight agents asthmagenic. Occup Med. 2000. 15:369–384.

13. Seed MJ, Cullinan P, Agius RM. Methods for the prediction of low-molecular-weight occupational respiratory sensitizers. Curr Opin Allergy Clin Immunol. 2008. 8:103–109.

14. Jarvis J, Seed MJ, Elton R, Sawyer L, Agius R. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup Environ Med. 2005. 62:243–250.

15. Piipari R, Keskinen H. Agents causing occupational asthma in Finland in 1986-2002: cow epithelium bypassed by moulds from moisture-damaged buildings. Clin Exp Allergy. 2005. 35:1632–1637.

16. Malo JL, Chan-Yeung M. Occupational asthma. J Allergy Clin Immunol. 2001. 108:317–328.

17. McDonald JC, Chen Y, Zekveld C, Cherry NM. Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med. 2005. 62:836–842.

18. Ameille J, Pauli G, Calastreng-Crinquand A, Vervloët D, Iwatsubo Y, Popin E, Bayeux-Dunglas MC, Kopferschmitt-Kubler MC. Reported incidence of occupational asthma in France, 1996-99: the ONAP programme. Occup Environ Med. 2003. 60:136–141.

19. Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG. Occupational asthma as identified by the Surveillance of Work-related and Occupational Respiratory Diseases programme in South Africa. Clin Exp Allergy. 2001. 31:32–39.

20. Elder D, Abramson M, Fish D, Johnson A, McKenzie D, Sim M. Surveillance of Australian workplace Based Respiratory Events (SABRE): notifications for the first 3.5 years and validation of occupational asthma cases. Occup Med (Lond). 2004. 54:395–399.

21. Vandenplas O, Larbanois A, Bugli C, Kempeneers E, Nemery B. The epidemiology of occupational asthma in Belgium. Rev Mal Respir. 2005. 22:421–430.

22. Orriols R, Costa R, Albanell M, Alberti C, Castejon J, Monso E, Panades R, Rubira N, Zock JP. Reported occupational respiratory diseases in Catalonia. Occup Environ Med. 2006. 63:255–260.

23. Oh SS, Kim KS. Occupational asthma in Korea. J Korean Med Sci. 2010. 25:S20–S25.

24. Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup Med (Lond). 2008. 58:169–174.

25. Monsó E, Magarolas R, Badorrey I, Radon K, Nowak D, Morera J. Occupational asthma in greenhouse flower and ornamental plant growers. Am J Respir Crit Care Med. 2002. 165:954–960.

26. Kim YK, Son JW, Kim HY, Park HS, Lee MH, Cho SH, Min KU, Kim YY. Citrus red mite (Panonychus citri) is the most common sensitizing allergen of asthma and rhinitis in citrus farmers. Clin Exp Allergy. 1999. 29:1102–1109.

27. Vandenplas O, Larbanois A, Vanassche F, François S, Jamart J, Vandeweerdt M, Thimpont J. Latex-induced occupational asthma: time trend in incidence and relationship with hospital glove policies. Allergy. 2009. 64:415–420.

28. Kogevinas M, Antó JM, Sunyer J, Tobias A, Kromhout H, Burney P. European Community Respiratory Health Survey Study Group. Occupational asthma in Europe and other industrialised areas: a population-based study. Lancet. 1999. 353:1750–1754.

29. Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, Radon K, Torén K, Alliksoo A, Benke G, Blanc PD, Dahlman-Hoglund A, D'Errico A, Héry M, Kennedy S, Kunzli N, Leynaert B, Mirabelli MC, Muniozguren N, Norbäck D, Olivieri M, Payo F, Villani S, van Sprundel M, Urrutia I, Wieslander G, Sunyer J, Antó JM. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet. 2007. 370:336–341.

30. Arif AA, Delclos GL, Whitehead LW, Tortolero SR, Lee ES. Occupational exposures associated with work-related asthma and work-related wheezing among U.S. workers. Am J Ind Med. 2003. 44:368–376.

31. Medina-Ramón M, Zock JP, Kogevinas M, Sunyer J, Torralba Y, Borrell A, Burgos F, Antó JM. Asthma, chronic bronchitis, and exposure to irritant agents in occupational domestic cleaning: a nested case-control study. Occup Environ Med. 2005. 62:598–606.

32. Mirabelli MC, Zock JP, Plana E, Antó JM, Benke G, Blanc PD, Dahlman-Höglund A, Jarvis DL, Kromhout H, Lillienberg L, Norbäck D, Olivieri M, Radon K, Sunyer J, Torén K, van Sprundel M, Villani S, Kogevinas M. Occupational risk factors for asthma among nurses and related healthcare professionals in an international study. Occup Environ Med. 2007. 64:474–479.

33. Rosenman KD, Reilly MJ, Schill DP, Valiante D, Flattery J, Harrison R, Reinisch F, Pechter E, Davis L, Tumpowsky CM, Filios M. Cleaning products and work-related asthma. J Occup Environ Med. 2003. 45:556–563.

34. Jones MG. Exposure-response in occupational allergy. Curr Opin Allergy Clin Immunol. 2008. 8:110–114.

35. Meredith SK, Bugler J, Clark RL. Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med. 2000. 57:830–836.

36. Pronk A, Preller L, Raulf-Heimsoth M, Jonkers IC, Lammers JW, Wouters IM, Doekes G, Wisnewski AV, Heederik D. Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med. 2007. 176:1090–1097.

37. Baur X. Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol. 2003. 90:11–18.

38. Heederik D, Houba R. An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann Occup Hyg. 2001. 45:175–185.

39. Jeal H, Draper A, Harris J, Taylor AN, Cullinan P, Jones M. Modified Th2 responses at high-dose exposures to allergen: using an occupational model. Am J Respir Crit Care Med. 2006. 174:21–25.

40. Matsui EC, Diette GB, Krop EJ, Aalberse RC, Smith AL, Eggleston PA. Mouse allergen-specific immunoglobulin G4 and risk of mouse skin test sensitivity. Clin Exp Allergy. 2006. 36:1097–1103.

41. Jacobs JH, Meijster T, Meijer E, Suarthana E, Heederik D. Wheat allergen exposure and the prevalence of work-related sensitization and allergy in bakery workers. Allergy. 2008. 63:1597–1604.

42. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet. 2001. 357:752–756.

43. Portengen L, de Meer G, Doekes G, Heederik D. Immunoglobulin G4 antibodies to rat urinary allergens, sensitization and symptomatic allergy in laboratory animal workers. Clin Exp Allergy. 2004. 34:1243–1250.

44. Hur GY, Koh DH, Kim HA, Park HJ, Ye YM, Kim KS, Park HS. Prevalence of work-related symptoms and serum-specific antibodies to wheat flour in exposed workers in the bakery industry. Respir Med. 2008. 102:548–555.

45. Nieuwenhuijsen MJ, Putcha V, Gordon S, Heederik D, Venables KM, Cullinan P, Newman-Taylor AJ. Exposure-response relations among laboratory animal workers exposed to rats. Occup Environ Med. 2003. 60:104–108.

46. Newman Taylor AJ, Cullinan P, Lympany PA, Harris JM, Dowdeswell RJ, du Bois RM. Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Respir Crit Care Med. 1999. 160:435–438.

47. Hollander A, Heederik D, Doekes G. Respiratory allergy to rats: exposure-response relationships in laboratory animal workers. Am J Respir Crit Care Med. 1997. 155:562–567.

48. Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM, McDonald JC, Taylor AJ. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J. 1999. 13:1139–1143.

49. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Natural history of sensitization, symptoms and occupational diseases in apprentices exposed to laboratory animals. Eur Respir J. 2001. 17:904–908.

50. Quirce S, Polo F, Figueredo E, González R, Sastre J. Occupational asthma caused by soybean flour in bakers--differences with soybean-induced epidemic asthma. Clin Exp Allergy. 2000. 30:839–846.

51. Vandenplas O, Cartier A, Lesage J, Cloutier Y, Perreault G, Grammer LC, Shaughnessy MA, Malo JL. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J Allergy Clin Immunol. 1993. 91:850–861.

52. Lemière C, Desjardins A, Cloutier Y, Drolet D, Perrault G, Cartier A, Malo JL. Occupational asthma due to formaldehyde resin dust with and without reaction to formaldehyde gas. Eur Respir J. 1995. 8:861–865.

53. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, Redlich CA. Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol. 2004. 113:1178–1184.

54. Ye YM, Kim CW, Kim HR, Kim HM, Suh CH, Nahm DH, Park HS, Redlich CA, Wisnewski AV. Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma. J Allergy Clin Immunol. 2006. 118:885–891.

55. Herrick CA, Xu L, Wisnewski AV, Das J, Redlich CA, Bottomly K. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol. 2002. 109:873–878.

56. Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, Hoet PH. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci. 2004. 80:310–321.

57. Vanoirbeek JA, Tarkowski M, Vanhooren HM, De Vooght V, Nemery B, Hoet PH. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol. 2006. 117:1090–1097.

58. Bello D, Herrick CA, Smith TJ, Woskie SR, Streicher RP, Cullen MR, Liu Y, Redlich CA. Skin exposure to isocyanates: reasons for concern. Environ Health Perspect. 2007. 115:328–335.

59. Bernstein JA, Alexis N, Bacchus H, Bernstein IL, Fritz P, Horner E, Li N, Mason S, Nel A, Oullette J, Reijula K, Reponen T, Seltzer J, Smith A, Tarlo SM. The health effects of non-industrial indoor air pollution. J Allergy Clin Immunol. 2008. 121:585–591.

60. Siracusa A, Marabini A, Folletti I, Moscato G. Smoking and occupational asthma. Clin Exp Allergy. 2006. 36:577–584.

61. Venables KM, Upton JL, Hawkins ER, Tee RD, Longbottom JL, Newman Taylor AJ. Smoking, atopy, and laboratory animal allergy. Br J Ind Med. 1988. 45:667–671.

62. Douglas JD, McSharry C, Blaikie L, Morrow T, Miles S, Franklin D. Occupational asthma caused by automated salmon processing. Lancet. 1995. 346:737–740.

63. Fuortes LJ, Weih L, Pomrehn P, Thorne PS, Jones M, Burmeister L, Merchant JA. Prospective epidemiologic evaluation of laboratory animal allergy among university employees. Am J Ind Med. 1997. 32:665–669.

64. Johnsen CR, Sorensen TB, Ingemann Larsen A, Bertelsen Secher A, Andreasen E, Kofoed GS, Fredslund Nielsen L, Gyntelberg F. Allergy risk in an enzyme producing plant: a retrospective follow up study. Occup Environ Med. 1997. 54:671–675.

65. Gautrin D, Cartier A, Howse D, Horth-Susin L, Jong M, Swanson M, Lehrer S, Fox G, Neis B. Occupational asthma and allergy in snow crab processing in Newfoundland and Labrador. Occup Environ Med. 2010. 67:17–23.

66. Radon K. The two sides of the "endotoxin coin". Occup Environ Med. 2006. 63:73–78. 10

67. Pacheco K, Maier L, Silveira L, Goelz K, Noteware K, Luna B, du Bois R, Murphy J, Rose C. Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals. J Allergy Clin Immunol. 2008. 122:896–902.e4.

68. Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy. 2000. 30:1519–1534.

69. Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005. 62:290–299.

70. Venables KM, Topping MD, Howe W, Luczynska CM, Hawkins R, Taylor AJ. Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br Med J (Clin Res Ed). 1985. 290:201–204.

71. Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ. Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study. Occup Environ Med. 1998. 55:684–691.

72. Baker DB, Gann PH, Brooks SM, Gallagher J, Bernstein IL. Cross-sectional study of platinum salts sensitization among precious metals refinery workers. Am J Ind Med. 1990. 18:653–664.

73. Merget R, Kulzer R, Dierkes-Globisch A, Breitstadt R, Gebler A, Kniffka A, Artelt S, Koenig HP, Alt F, Vormberg R, Baur X, Schultze-Werninghaus G. Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J Allergy Clin Immunol. 2000. 105:364–370.

74. Matsui EC, Krop EJ, Diette GB, Aalberse RC, Smith AL, Eggleston PA. Mouse allergen exposure and immunologic responses: IgE-mediated mouse sensitization and mouse specific IgG and IgG4 levels. Ann Allergy Asthma Immunol. 2004. 93:171–178.

75. Hollander A, Doekes G, Heederik D. Cat and dog allergy and total IgE as risk factors of laboratory animal allergy. J Allergy Clin Immunol. 1996. 98:545–554.

76. Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med. 2001. 163:899–904.

77. Krop EJ, Heederik DJ, Lutter R, de Meer G, Aalberse RC, Jansen HM, van der Zee JS. Associations between pre-employment immunologic and airway mucosal factors and the development of occupational allergy. J Allergy Clin Immunol. 2009. 123:694–700.e3.

78. Bignon JS, Aron Y, Ju LY, Kopferschmitt MC, Garnier R, Mapp C, Fabbri LM, Pauli G, Lockhart A, Charron D, et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med. 1994. 149:71–75.

79. Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J. 1996. 9:207–210.

80. Mapp CE, Beghè B, Balboni A, Zamorani G, Padoan M, Jovine L, Baricordi OR, Fabbri LM. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy. 2000. 30:651–656.

81. Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med. 1995. 151:219–221.

82. Jones MG, Nielsen J, Welch J, Harris J, Welinder H, Bensryd I, Skerfving S, Welsh K, Venables KM, Taylor AN. Association of HLA-DQ5 and HLA-DR1 with sensitization to organic acid anhydrides. Clin Exp Allergy. 2004. 34:812–816.

83. Horne C, Quintana PJ, Keown PA, Dimich-Ward H, Chan-Yeung M. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur Respir J. 2000. 15:911–914.

84. Rihs HP, Chen Z, Ruëff F, Cremer R, Raulf-Heimsoth M, Baur X, Moneret-Vautrin DA, Brüning T. HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy. J Allergy Clin Immunol. 2002. 110:507–514.

85. Jeal H, Draper A, Jones M, Harris J, Welsh K, Taylor AN, Cullinan P. HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies? J Allergy Clin Immunol. 2003. 111:795–799.

86. Choi JH, Lee KW, Kim CW, Park CS, Lee HY, Hur GY, Kim SH, Hong CS, Jang AS, Park HS. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Int Arch Allergy Immunol. 2009. 150:156–163.

87. Rihs HP, Barbalho-Krölls T, Huber H, Baur X. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am J Ind Med. 1997. 32:522–527.

88. Bernstein JA, Munson J, Lummus ZL, Balakrishnan K, Leikauf G. T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma. J Allergy Clin Immunol. 1997. 99:245–250.

89. Beghe B, Padoan M, Moss CT, Barton SJ, Holloway JW, Holgate ST, Howell WM, Mapp CE. Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy. 2004. 59:61–64.

90. Bernstein DI, Wang N, Campo P, Chakraborty R, Smith A, Cartier A, Boulet LP, Malo JL, Yucesoy B, Luster M, Tarlo SM, Hershey GK. Diisocyanate asthma and gene-environment interactions with IL-4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol. 2006. 97:800–806.

91. Wisnewski AV, Liu Q, Liu J, Redlich CA. Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates. Clin Exp Allergy. 2008. 38:957–967.

92. Ye YM, Kang YM, Kim SH, Kim CW, Kim HR, Hong CS, Park CS, Kim HM, Nahm DH, Park HS. Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma. Clin Exp Allergy. 2006. 36:1153–1160.

93. Piirilä P, Wikman H, Luukkonen R, Kääriä K, Rosenberg C, Nordman H, Norppa H, Vainio H, Hirvonen A. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics. 2001. 11:437–445.

94. Wikman H, Piirilä P, Rosenberg C, Luukkonen R, Kääriä K, Nordman H, Norppa H, Vainio H, Hirvonen A. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics. 2002. 12:227–233.

95. Mapp CE, Fryer AA, De Marzo N, Pozzato V, Padoan M, Boschetto P, Strange RC, Hemmingsen A, Spiteri MA. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol. 2002. 109:867–872.

96. Berode M, Jost M, Ruegger M, Savolainen H. Host factors in occupational diisocyanate asthma: a Swiss longitudinal study. Int Arch Occup Environ Health. 2005. 78:158–163.

97. Kim SH, Cho BY, Park CS, Shin ES, Cho EY, Yang EM, Kim CW, Hong CS, Lee JE, Park HS. Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin Exp Allergy. 2009. 39:203–212.

98. Mapp CE. What is the role of genetics in occupational asthma? Eur Respir J. 2009. 33:459–460.

99. Gautrin D, Ghezzo H, Infante-Rivard C, Magnan M, L'Archevêque J, Suarthana E, Malo JL. Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents. Am J Respir Crit Care Med. 2008. 177:871–879.

100. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999. 104:301–304.

101. Boutet K, Malo JL, Ghezzo H, Gautrin D. Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax. 2007. 62:260–264.

102. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, Wjst M, Cerveri I, Pin I, Bousquet J, Jarvis D, Burney PG, Neukirch F, Leynaert B. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008. 372:1049–1057.

103. Vandenplas O, Van Brussel P, D'Alpaos V, Wattiez M, Jamart J, Thimpont J. Rhinitis in subjects with work-exacerbated asthma. Respir Med. 2010. 104:497–503.

104. Karjalainen A, Martikainen R, Klaukka T, Saarinen K, Uitti J. Risk of asthma among Finnish patients with occupational rhinitis. Chest. 2003. 123:283–288.

105. Elliott L, Heederik D, Marshall S, Peden D, Loomis D. Progression of self-reported symptoms in laboratory animal allergy. J Allergy Clin Immunol. 2005. 116:127–132.

106. Moscato G, Vandenplas O, Gerth Van Wijk R, Malo JL, Quirce S, Walusiak J, Castano R, De Groot H, Folletti I, Gautrin D, Yacoub MR, Perfetti L, Siracusa A. Occupational rhinitis. Allergy. 2008. 63:969–980.

107. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Host determinants for the development of allergy in apprentices exposed to laboratory animals. Eur Respir J. 2002. 19:96–103.

108. Howse D, Gautrin D, Neis B, Cartier A, Horth-Susin L, Jong M, Swanson MC. Gender and snow crab occupational asthma in Newfoundland and Labrador, Canada. Environ Res. 2006. 101:163–174.